Janney Montgomery Scott’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-5,667
Closed -$358K 2156
2020
Q2
$358K Sell
5,667
-1,948
-26% -$134K ﹤0.01% 1532
2020
Q1
$389K Buy
7,615
+900
+13% +$60.3K ﹤0.01% 1358
2019
Q4
$534K Sell
6,715
-625
-9% -$37K ﹤0.01% 1391
2019
Q3
$356K Sell
7,340
-250
-3% -$13K ﹤0.01% 1589
2019
Q2
$399K Buy
7,590
+2,735
+56% +$157K ﹤0.01% 1555
2019
Q1
$257K Buy
+4,855
New +$239K ﹤0.01% 1738

Other funds holding GBT

Janney Montgomery Scott's GBT Position: Q3 2020 in Review

Janney Montgomery Scott sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2020, closing a stake of 5,667 shares — an estimated $358K sold.

Janney Montgomery Scott first reported a position in GBT in Q1 2019 and held it in 6 quarters. The position peaked at $534K in Q4 2019. 229 funds tracked by Wall St. Rank hold GBT as of Q3 2020.

  • Janney Montgomery Scott reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2020 after selling out during the quarter.
  • Janney Montgomery Scott sold 5,667 Global Blood Therapeutics, Inc. shares in Q3 2020, an estimated $358K.
  • Janney Montgomery Scott first reported a position in Global Blood Therapeutics, Inc. in Q1 2019 and held it in 6 quarters.
  • Janney Montgomery Scott's Global Blood Therapeutics, Inc. position peaked at $534K in Q4 2019.
  • 229 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2020.

Based on Janney Montgomery Scott's 13F filing for Q3 2020, filed 6 Nov 2020.